Metraipolis › archive › dc_f1982cc66599

Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials — Europe PMC PMID:41580831

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41580831
DOI: 10.1186/s40360-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-11-06T12:49:24.551Z
SHA-256 of the archived text: 6d4a362696f2a27d52b5f699a66b2907ce1e01f299a00f8055907d163c0d91bd
Stable URL of this page: https://metraipolis.com/documento/dc_f1982cc66599

How to cite

Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials — Europe PMC PMID:41580831 — Europe PMC (en), https://europepmc.org/article/MED/41580831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1982cc66599 (Metraipolis archive dc_f1982cc66599, sha256 6d4a362696f2a27d52b5f699a66b2907ce1e01f299a00f8055907d163c0d91bd)

BibTeX

@misc{dcf1982cc66599,
  title = {Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials — Europe PMC PMID:41580831},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41580831},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1982cc66599; sha256 6d4a362696f2a27d52b5f699a66b2907ce1e01f299a00f8055907d163c0d91bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41580831. Agents can read the archived copy with the MCP tool read_document.